Critical Appraisal Of Eculizumab For Atypical Hemolytic Uremic Syndrome.

dc.creatorPalma LM
dc.creatorLangman CB.
dc.date2016
dc.date2016-11-10T13:32:04Z
dc.date2016-11-10T13:32:04Z
dc.date.accessioned2018-03-29T01:57:08Z
dc.date.available2018-03-29T01:57:08Z
dc.identifierJournal Of Blood Medicine. v. 2016, p. 39-72
dc.identifier
dc.identifierhttps://dx.doi.org/10.2147/JBM.S36249
dc.identifierhttps://www.dovepress.com/critical-appraisal-of-eculizumab-for-atypical-hemolytic-uremic-syndrom-peer-reviewed-article-JBM
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/318363
dc.identifier27110144
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1309245
dc.description2016
dc.description39
dc.description72
dc.relationJournal Of Blood Medicine
dc.rightsaberto
dc.sourcePubMed
dc.titleCritical Appraisal Of Eculizumab For Atypical Hemolytic Uremic Syndrome.
dc.title
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución